Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Life sciences careers

- PMLiVE

Pharma frustration mounts as Johnson toys with no-deal Brexit pronouncements

No new government funds committed to no-deal medicines plans

- PMLiVE

Threat of no-deal damaging life sciences, says UK biotech leader

Calls for better-informed debate among Conservative candidates

- PMLiVE

Johnson retains lead after second Tory leadership vote

Meets business leaders to reassure on no-deal Brexit

- PMLiVE

Trump backtracks on ‘NHS on the table’ comments

Echoes mixed message at home about healthcare

- PMLiVE

Hancock says “NHS not for sale” in post-Brexit US trade talks

Tensions rise as President Trump arrives for state visit

- PMLiVE

UK pharma’s hard-to-recruit posts need foreign recruitment boost

Post-Brexit immigration policy still unclear

- PMLiVE

Deal or no deal? Brexit battlelines drawn in Tory leadership bids

Pharma industry warns again on no-deal impact

- PMLiVE

As Europe goes to polls, pharma seeks to keep healthcare, R&D a priority

Eurosceptics want to block greater EU integration

- PMLiVE

No deal or revoke looming as fourth vote on Brexit nears

Voters set to protest via EU elections, no-deal remains possibility

- PMLiVE

Tax credit changes could put a ‘hard brake’ on UK biotech

Anti-fraud measures will hit genuine firms, fears BIA

- PMLiVE

Brexit “having impact on EU drug development”

EMA and UK regulator both affected

- PMLiVE

Novartis and Sanofi heads take on UK pharma leadership roles

Sector must fight for best Brexit outcome

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links